简体中文 | 繁體中文 | English

Press Releases

2024-01-12 12:29 ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer
2024-01-12 11:43 Kinaxis Rolls Out New Innovations to Revolutionize Stretched Retail Supply Chains
2024-01-12 11:18 Wemade Presents MIR4 New Year’s Event ‘Search for the Blue Cintamani Stone’!
2024-01-12 11:08 SPIE, the international society for optics and photonics, announces its 2024 Society awards
2024-01-12 11:01 Former IAM Editor-in-Chief Takes Key Role at Sisvel
2024-01-12 10:13 Alvarez & Marsal Announces 2024 Managing Director Promotions
2024-01-11 18:19 InvestCloud Appoints Jeff Yabuki as Chairman and CEO
2024-01-11 18:14 Chaired by His Highness the Minister of Foreign Affairs, High-level Delegation From Saudi Arabia to Participate in World Economic Forum Annual Meeting 2024
2024-01-11 10:23 SLB Announces Collaboration with Geminus AI
2024-01-11 10:19 Quectel Introduces Ultra-Low Power, Cost-Effective KG200Z Long Range Module
2024-01-11 10:13 QPS Significantly Enhances Mass Spectrometry Laboratory Capacity
2024-01-11 10:07 Cognite Announces Beta Launch of Generative AI-Powered Remote Operations Control Room for Celanese Clear Lake Facility
2024-01-11 09:58 Lifezone Metals Announces Completion of Funding for Phase 1 Platinum, Palladium and Rhodium Recycling Joint Venture with Glencore
2024-01-11 09:25 Emaar Hospitality Group Continues its Legacy: Unveiling the Transformation of Address Fountain Views to the iconic Address Dubai Mall
2024-01-11 09:20 Lenovo Unleashes AI-Powered Creativity and Productivity Devices and Solutions at CES 2024
2024-01-11 09:16 Rimini Street Earns Prestigious Great Place to Work® Certifications for Second Consecutive Year in France, UK, and USA
2024-01-11 09:12 LambdaTest Integrates with New Relic to Deliver Unmatched Test Observability
2024-01-11 09:10 Medidata Secures Top Honors in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
2024-01-11 09:07 1NCE Upgrades IoT Software Platform with Plugins
2024-01-11 09:03 Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Business Wire Weibo

Industries

Latest Releases